Miles W. McHugh - 10 Jun 2021 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role: Sr VP & Princ. Acctg Officer
Signature: /s/ Miles W. McHugh
Issuer symbol: N/A
Transactions as of: 10 Jun 2021
Net transactions value: -$138,764
Form type: 4
Filing time: 11 Jun 2021, 17:00:16 UTC
Next filing: 03 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HZNP	Ordinary Shares	Options Exercise		+3,334	+9.6%		37,998	10 Jun 2021	Direct	F1, F2
transaction	HZNP	Ordinary Shares	Tax liability	$138,764	-1,477	-3.9%	$93.95	36,521	10 Jun 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HZNP	Restricted Stock Units (RSU)	Options Exercise	$0	-3,334	-100%	$0.000000^*	0	10 Jun 2021	Ordinary Shares	3,334		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each RSU represents a contingent right to receive one ordinary share of the Issuer.
F2	Includes 1,049 ordinary shares of the Issuer acquired by the reporting person on June 1, 2021 pursuant to an employee stock purchase program.
F3	On June 10, 2018, the reporting person was granted 10,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.